Selective Serotonin Reuptake Inhibitors and Associated Bleeding Risks: A Narrative and Clinical Review
Major Depressive Disorder (MDD) is a major cause of disability worldwide and is associated with serious lasting impairment. A leading hypothesis of the pathophysiology of MDD is the monoamine deficiency hypothesis which suggests that depression is caused by depletion of serotonin, norepinephrine, or...
Saved in:
Main Authors: | Amber N. Edinoff, Keerthiga Raveendran, Marc A. Colon, Bennett H. Thomas, Katie A. Trettin, Grace W. Hunt, Adam M. Kaye, Elyse M. Cornett, Alan D. Kaye |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Medical Publishing
2022-11-01
|
Series: | Health Psychology Research |
Online Access: | https://doi.org/10.52965/001c.39580 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Look at Commonly Utilized Serotonin Noradrenaline Reuptake Inhibitors (SNRIs) in Chronic Pain
by: Christopher Robinson, et al.
Published: (2022-05-01) -
Lumateperone tosylate, A Selective and Concurrent Modulator of Serotonin, Dopamine, and Glutamate, in the Treatment of Schizophrenia
by: Kunal Maini, et al.
Published: (2021-06-01) -
Phenothiazines and their Evolving Roles in Clinical Practice: A Narrative Review
by: Amber N. Edinoff, et al.
Published: (2022-11-01) -
Viloxazine, a Non-stimulant Norepinephrine Reuptake Inhibitor, for the Treatment of Attention Deficit Hyperactivity Disorder: A 3 Year Update
by: Hannah W Haddad, et al.
Published: (2022-07-01) -
Methamphetamine Use: A Narrative Review of Adverse Effects and Related Toxicities
by: Amber N. Edinoff, et al.
Published: (2022-09-01)